Margaret Susan Carter, MD
Otolaryngology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 32
- 9 carriers
- Offices
- 3
Offices
3 locations · Bass Medical Group · 292 clinicians in this group
Looking this up.
Hospitals listed: Good Samaritan Hospital. That is not proof they admit you there this week.
Plans that list them
32 plans · 9 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Carter’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
32 of 32 plans
| Advantage Care (HMO) | Align Senior Care | Listed | Oct 1, 2026 |
| Premier Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Senior Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A136997 · Current
Licensed to practise in California · since 2015 · expires 2026-12-31 · Loyola University of Chicago Stritch School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$101,165
Medicare paid this office $101,165 for 269 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Diagnostic exam of voice box using a flexible endoscope | 167 | $24,234 | $122 |
| Return visit (30+ min) | 111 | $13,951 | $106 |
| Short return visit (20+ min) | 107 | $12,886 | $83 |
| New patient visit (30+ min) | 76 | $7,633 | $100 |
| Biopsy or removal of nasal polyp or tissue using an endoscope | 14 | $6,719 | $336 |
See all 11 services
| Diagnostic exam of voice box using a flexible endoscope | 167 | $24,234 | $122 |
| Return visit (30+ min) | 111 | $13,951 | $106 |
| Short return visit (20+ min) | 107 | $12,886 | $83 |
| New patient visit (30+ min) | 76 | $7,633 | $100 |
| Biopsy or removal of nasal polyp or tissue using an endoscope | 14 | $6,719 | $336 |
| Long return visit (40+ min) | 35 | $6,457 | $166 |
| New patient visit (45+ min) | 33 | $4,588 | $139 |
| Removal of impacted ear wax | 53 | $2,468 | $34 |
| Removal of nasal air passage under lining tissue | 14 | $1,836 | $131 |
| Computer-assisted procedure outside membrane covering brain | 11 | $1,760 | $147 |
| Exam of ear using a microscope | 11 | $899 | $30 |
Procedures Medicare counted
| Removal of tissue | 1-10 | None |
Who their Medicare patients are
269 Original Medicare patients in 2024. Average age 75 · Women 61% · Health risk score 0.98. At or below the middle of the specialty; the typical otolaryngology clinician is at 1.19.
Conditions among them: High blood pressure 71% · Coronary heart disease 32% · Diabetes 23% · Atrial fibrillation 19% · Heart failure 15% · Cancer 15% · Chronic kidney disease 14% · COPD 13% · Depression 12% · Stroke 9% · Dementia 4%.
The office billed $438,532, Medicare allowed $136,619 and paid $101,165; for 860 services of 36 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 269 | 860 | 75 | 0.98 | $438,532 | $101,165 |
| 2023 | 262 | 926 | 75 | 1.01 | $555,471 | $124,101 |
| 2022 | 284 | 919 | 76 | 1.09 | $423,285 | $101,790 |
| 2021 | 245 | 748 | 76 | 0.93 | $315,241 | $78,232 |
| 2020 | 199 | 642 | 75 | 1.04 | $240,029 | $56,195 |
| 2019 | 175 | 573 | 75 | 1.03 | $209,070 | $49,697 |
| 2018 | 255 | 760 | 75 | 1.06 | $246,367 | $57,613 |
| 2017 | 370 | 1,079 | 76 | 1.09 | $343,839 | $87,803 |
| 2016 | 198 | 843 | 75 | 1.11 | $217,165 | $83,434 |
| 2015 | 76 | 225 | 76 | 0.87 | $38,676 | $17,598 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| Diagnostic exam of voice box using a flexible endoscope | 134 | $22,599 | $128 |
| Short return visit (20+ min) | 137 | $16,734 | $85 |
| Return visit (30+ min) | 105 | $13,753 | $108 |
| Long return visit (40+ min) | 53 | $9,957 | $161 |
| Biopsy or removal of nasal polyp or tissue using an endoscope | 15 | $6,769 | $376 |
| New patient visit (45+ min) | 34 | $4,711 | $139 |
| New patient visit (60+ min) | 24 | $4,660 | $194 |
| Removal of nasal sinus tissue using an endoscope | 17 | $4,310 | $254 |
| New patient visit (30+ min) | 39 | $4,170 | $107 |
| Removal of impacted ear wax | 47 | $2,602 | $41 |
| Removal of nasal air passage under lining tissue | 21 | $2,594 | $124 |
| Computer-assisted procedure outside membrane covering brain | 16 | $2,489 | $156 |
| Exam of ear using a microscope | 21 | $716 | $29 |
2022: 12 services
| Diagnostic exam of voice box using a flexible endoscope | 107 | $19,714 | $128 |
| Short return visit (20+ min) | 150 | $17,947 | $81 |
| Return visit (30+ min) | 130 | $17,325 | $106 |
| Long return visit (40+ min) | 39 | $7,043 | $157 |
| Biopsy or removal of nasal polyp or tissue using an endoscope | 12 | $6,259 | $348 |
| New patient visit (45+ min) | 35 | $4,947 | $141 |
| Removal of impacted ear wax | 83 | $3,862 | $37 |
| New patient visit (60+ min) | 16 | $3,149 | $197 |
| New patient visit (30+ min) | 29 | $2,734 | $94 |
| Removal of nasal air passage under lining tissue | 11 | $1,464 | $133 |
| Short return visit | 16 | $1,006 | $50 |
| Exam of ear using a microscope | 25 | $940 | $30 |
2021: 8 services
| Return visit (30+ min) | 128 | $21,374 | $116 |
| Diagnostic exam of voice box using a flexible endoscope | 84 | $14,192 | $126 |
| Short return visit (20+ min) | 114 | $14,137 | $80 |
| New patient visit (45+ min) | 41 | $5,866 | $143 |
| Removal of impacted ear wax | 80 | $4,422 | $40 |
| Long return visit (40+ min) | 22 | $3,398 | $136 |
| New patient visit (30+ min) | 17 | $1,536 | $90 |
| Exam of ear using a microscope | 13 | $661 | $30 |
2020: 6 services
| Short return visit (20+ min) | 138 | $15,936 | $66 |
| Diagnostic exam of voice box using a flexible endoscope | 61 | $9,802 | $113 |
| Return visit (30+ min) | 68 | $8,952 | $104 |
| New patient visit (30+ min) | 52 | $5,141 | $99 |
| Removal of impacted ear wax | 48 | $2,483 | $41 |
| Exam of ear using a microscope | 19 | $768 | $27 |
2019: 6 services
| Short return visit (20+ min) | 114 | $14,975 | $64 |
| Diagnostic exam of voice box using a flexible endoscope | 55 | $9,358 | $104 |
| Return visit (30+ min) | 71 | $8,052 | $95 |
| New patient visit (30+ min) | 45 | $4,285 | $95 |
| Removal of impacted ear wax | 29 | $1,685 | $40 |
| Exam of ear using a microscope | 12 | $456 | $28 |
2018: 8 services
| Short return visit (20+ min) | 148 | $15,899 | $59 |
| Diagnostic exam of voice box using a flexible endoscope | 58 | $8,068 | $96 |
| Return visit (30+ min) | 62 | $7,098 | $95 |
| New patient visit (30+ min) | 82 | $6,420 | $78 |
| Removal of impacted ear wax | 58 | $2,549 | $37 |
| New patient visit (45+ min) | 17 | $2,384 | $140 |
| Short return visit | 33 | $1,455 | $36 |
| Exam of ear using a microscope | 31 | $788 | $23 |
2017: 11 services
| Short return visit (20+ min) | 202 | $21,998 | $63 |
| Return visit (30+ min) | 105 | $12,708 | $95 |
| New patient visit (45+ min) | 62 | $8,153 | $132 |
| New patient visit (30+ min) | 87 | $7,643 | $88 |
| Diagnostic exam of voice box using a flexible endoscope | 66 | $7,159 | $99 |
| Removal of impacted ear wax | 117 | $6,065 | $42 |
| New patient visit (60+ min) | 24 | $3,848 | $160 |
| Exam of ear using a microscope | 50 | $1,850 | $29 |
| Long return visit (40+ min) | 13 | $1,654 | $127 |
| Removal of inflamed or infected skin, up to 10% of body surface | 25 | $1,376 | $47 |
| Short return visit | 24 | $1,129 | $40 |
2016: 7 services
| Return visit (30+ min) | 116 | $23,405 | $97 |
| New patient visit (45+ min) | 112 | $15,621 | $139 |
| Exam of the nose and throat using an endoscope | 68 | $9,981 | $112 |
| Short return visit (20+ min) | 73 | $6,394 | $67 |
| Exam of ear using a microscope | 100 | $4,877 | $30 |
| New patient visit (60+ min) | 12 | $2,013 | $168 |
| Removal of inflamed or infected skin, up to 10% of body surface | 14 | $1,441 | $51 |
2015: 6 services
| New patient visit (45+ min) | 20 | $3,052 | $153 |
| Exam of the nose and throat using an endoscope | 17 | $2,952 | $141 |
| Short return visit (20+ min) | 29 | $2,613 | $69 |
| New patient visit (30+ min) | 21 | $2,130 | $101 |
| Short return visit | 28 | $1,516 | $41 |
| Exam of ear using a microscope | 37 | $1,467 | $31 |
Drugs they prescribed that Part D paid
$8,913
Pharmacies billed $8,913 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (13 of 525) in 2024. At or below the middle of the specialty; the typical otolaryngology clinician is at 4%.
523 generic and fewer than 11 brand-name prescriptions · $8,913 in drug cost · 96 antibiotic prescriptions to 72 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ipratropium | 66 | $2,168 | $33 |
| Azelastine | 43 | $2,094 | $49 |
| Mupirocin | 104 | $667 | $6 |
| Montelukast | 76 | $592 | $8 |
| Clarithromycin | 16 | $426 | $27 |
See all 12 drugs
| Ipratropium | 66 | $2,168 | $33 |
| Azelastine | 43 | $2,094 | $49 |
| Mupirocin | 104 | $667 | $6 |
| Montelukast | 76 | $592 | $8 |
| Clarithromycin | 16 | $426 | $27 |
| Ofloxacin | 23 | $403 | $18 |
| Amoxicillin-Clavulanate Potass | 23 | $218 | $9 |
| Levofloxacin | 21 | $208 | $10 |
| Omeprazole | 24 | $164 | $7 |
| Ciprofloxacin | 13 | $147 | $11 |
| Famotidine | 25 | $91 | $4 |
| Oxycodone | 12 | $56 | $5 |
Year by year
| 2024 | 525 | 196 | 3% (13) | None | $8,913 |
| 2023 | 609 | 197 | 3% (16) | None | $12,016 |
| 2022 | 623 | 187 | None | None | $16,167 |
| 2021 | 547 | 166 | None | None | $14,008 |
| 2020 | 486 | 151 | None | None | $12,532 |
| 2019 | 355 | 109 | None | None | $9,102 |
| 2018 | 436 | 125 | None | None | $11,008 |
| 2017 | 492 | 118 | None | 3% | $9,808 |
| 2016 | 424 | 120 | 3% (12) | 7% | $12,305 |
| 2015 | 99 | 47 | 12% (12) | 12% | $3,956 |
| 2014 | 59 | 44 | 48% (28) | None | $802 |
| 2013 | 54 | 33 | 30% (16) | None | $1,654 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 13 drugs
| Azelastine | 95 | $3,548 | $37 |
| Ipratropium | 47 | $2,000 | $43 |
| Mupirocin | 121 | $1,306 | $11 |
| Montelukast | 90 | $1,194 | $13 |
| Clotrimazole | 11 | $468 | $43 |
| Amoxicillin-Clavulanate Potass | 26 | $424 | $16 |
| Clarithromycin | 11 | $416 | $38 |
| Levofloxacin | 34 | $351 | $10 |
| Ofloxacin | 15 | $315 | $21 |
| Famotidine | 34 | $302 | $9 |
| Ondansetron Odt | 18 | $229 | $13 |
| Omeprazole | 17 | $189 | $11 |
| Oxycodone | 16 | $78 | $5 |
2022: 12 drugs
| Azelastine | 129 | $6,573 | $51 |
| Ipratropium | 56 | $2,894 | $52 |
| Montelukast | 78 | $1,164 | $15 |
| Mupirocin | 120 | $1,045 | $9 |
| Ofloxacin | 22 | $502 | $23 |
| Omeprazole | 26 | $415 | $16 |
| Famotidine | 31 | $390 | $13 |
| Amoxicillin-Clavulanate Potass | 18 | $307 | $17 |
| Ondansetron Odt | 12 | $126 | $10 |
| Lidocaine Hcl Viscous | 13 | $124 | $10 |
| Sulfamethoxazole-Trimethoprim | 14 | $88 | $6 |
| Cephalexin | 12 | $69 | $6 |
2021: 10 drugs
| Azelastine | 115 | $4,820 | $42 |
| Ipratropium | 43 | $2,171 | $50 |
| Montelukast | 61 | $1,077 | $18 |
| Mupirocin | 118 | $1,073 | $9 |
| Clarithromycin | 17 | $537 | $32 |
| Famotidine | 31 | $499 | $16 |
| Clotrimazole | 11 | $485 | $44 |
| Omeprazole | 29 | $407 | $14 |
| Amoxicillin-Clavulanate Potass | 15 | $246 | $16 |
| Triamterene-Hydrochlorothiazid | 18 | $129 | $7 |
2020: 7 drugs
| Ipratropium | 63 | $2,998 | $48 |
| Azelastine | 72 | $2,747 | $38 |
| Montelukast | 91 | $1,352 | $15 |
| Fluocinolone Acetonide Oil | 11 | $942 | $86 |
| Mupirocin | 87 | $711 | $8 |
| Ofloxacin | 27 | $613 | $23 |
| Omeprazole | 19 | $339 | $18 |
2019: 6 drugs
| Ipratropium | 63 | $2,770 | $44 |
| Azelastine | 48 | $2,508 | $52 |
| Montelukast | 59 | $665 | $11 |
| Mupirocin | 51 | $474 | $9 |
| Ranitidine | 30 | $293 | $10 |
| Omeprazole | 20 | $117 | $6 |
2018: 7 drugs
| Ipratropium | 80 | $2,983 | $37 |
| Azelastine | 40 | $2,193 | $55 |
| Montelukast | 56 | $942 | $17 |
| Ranitidine | 64 | $884 | $14 |
| Omeprazole | 37 | $492 | $13 |
| Mupirocin | 47 | $430 | $9 |
| Triamterene-Hydrochlorothiazid | 16 | $68 | $4 |
2017: 8 drugs
| Ipratropium | 68 | $2,189 | $32 |
| Azelastine | 50 | $2,180 | $44 |
| Ranitidine | 93 | $853 | $9 |
| Montelukast | 58 | $508 | $9 |
| Ofloxacin | 23 | $412 | $18 |
| Mupirocin | 37 | $389 | $11 |
| Omeprazole | 37 | $199 | $5 |
| Amoxicillin-Clavulanate Potass | 13 | $183 | $14 |
2016: 10 drugs
| Fluocinolone Acetonide Oil | 12 | $1,940 | $162 |
| Azelastine | 35 | $1,603 | $46 |
| Ipratropium | 47 | $1,073 | $23 |
| Amoxicillin-Clavulanate Potass | 23 | $535 | $23 |
| Ofloxacin | 27 | $511 | $19 |
| Montelukast | 42 | $430 | $10 |
| Ranitidine | 42 | $383 | $9 |
| Omeprazole | 28 | $315 | $11 |
| Clindamycin | 19 | $233 | $12 |
| Prednisone | 18 | $204 | $11 |
2015: 2 drugs
| Ranitidine | 18 | $130 | $7 |
| Omeprazole | 12 | $113 | $9 |
Money from drug and device companies
$314 in 2024
| 2024 | 3 | 3 | None | $314 |
| 2019 | 1 | 1 | None | $44 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Neurent Medical | Neuromark Device | $201 | 1 payment
|
| Medtronic | Venaseal | $82 | 1 payment
|
| Smith+Nephew | Tula | $32 | 1 payment
|
See all 3 published payments
| Smith+Nephew | Meals · 2024-07-24 | Tula | $32 |
| Medtronic | Meals · 2024-04-10 | Venaseal | $82 |
| Neurent Medical | Meals · 2024-03-22 | Neuromark Device | $201 |
See earlier years (2019)
2019: $44
| Smith+Nephew | Coblation Wands | $44 | 1 payment
|
Checkups this office reported
18 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 87.3 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 62%That's more than half. | 581 |
| Blood pressure under controlPeople with high blood pressure whose reading was in a healthy range | 63%That's more than half. | 111 |
| Bone-density scans that were not neededYounger women who got a bone scan without a medical reason | 1%That's few of the people this applied to. Better on this measure. | 95 |
| Breast cancer screeningEligible women who got a mammogram | 36%That's less than half. | 264 |
| Cervical cancer screeningEligible women who got a Pap or HPV test | 17%That's few of the people this applied to. | 369 |
| Checked for fall riskOlder patients screened for fall risk | 16%That's few of the people this applied to. | 354 |
| Childhood Immunization StatusAs Medicare defines this measure | 62% | 34 |
| Chlamydia Screening for WomenAs Medicare defines this measure | 9% | 23 |
See the other 10 measures
| Colon cancer screeningEligible adults who got a colon cancer test | 25%That's less than half. | 558 |
| Depression screeningPatients screened for depression, with a follow-up plan if needed | 6%That's few of the people this applied to. | 1,104 |
| Diabetes eye examPeople with diabetes who got a retinal eye exam | 17%That's few of the people this applied to. | 23 |
| Diabetes poorly controlledPeople with diabetes whose blood sugar stayed very high | 39%That's less than half. Better on this measure. | 23 |
| HIV screeningEligible patients who were screened for HIV | 11%That's few of the people this applied to. | 816 |
| Medications listed in the chartVisits where the current medication list was documented | 96%That's most of the people this applied to. | 1,936 |
| Patients can see their records onlinePatients who were given electronic access to their health information | 74%That's more than half. | 571 |
| Prescriptions sent electronicallyPrescriptions sent to the pharmacy by computer instead of paper | 100%That's most of the people this applied to. | 608 |
| Statin prescribed when it protects the heartPeople at cardiovascular risk who were prescribed a statin | 73%That's more than half. | 187 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 40%That's less than half. | 1,104 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Agreed to federal review of their records system
- Checks the state prescription-drug database before prescribing
- Did a security review of patient data
- Exchanges records both ways with other health systems
- Improved the patient portal
- Lets patients read their visit notes
- Shows lab and imaging costs when ordering tests
- Uses standard treatment protocols
- Exempt from electronic case reporting
- Exempt from immunization registry reporting
Professional record
- NPI
- 1790009215
- Licence
- CA A136997California A136997: Current · expires 2026-12-31
- Trained
- Loyola University of Chicago, Stritch School of Medicine, 2010
- Group
- Bass Medical Group
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Otolaryngology (207Y00000X)
- Mailing address
- 6060 Hellyer Ave, Suite 150, San Jose, CA, 95138
- NPI first listed
- 2010-03-26
- NPI last updated
- 2015-07-21
This is when the NPI record was last certified, not a medical board exam.